Press Release


Incyte Investor Conference Update

17 June, 2020

WILMINGTON, Del.--(BUSINESS WIRE)--Jun. 17, 2020-- Incyte (Nasdaq:INCY) has updated its presentation time at the following investor conference:

  • JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020, now at 3:00 p.m. (EDT).

The presentation at the BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 p.m. (EDT) is unchanged.

The presentations for both conferences will be webcast live and can be accessed at Replays will be available for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.

Catalina Loveman, +1 302 498 6171

Michael Booth, DPhil, +1 302 498 5914

Source: Incyte